Weiyi Qu
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD.
Journal: Gut
Published: July 02, 2025
Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2.
Journal: Journal of lipid research
Published: January 21, 2025
Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression.
Journal: Science translational medicine
Published: February 14, 2024
Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD.
Journal: Journal of lipid research
Published: November 10, 2023
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis.
Journal: The Journal of clinical investigation
Published: June 20, 2023
Pulmonary Artery Denervation Inhibits Left Stellate Ganglion Stimulation-Induced Ventricular Arrhythmias Originating From the RVOT.
Journal: JACC. Clinical electrophysiology
Published: March 10, 2022
Profound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder Model.
Journal: Frontiers in endocrinology
Published: January 05, 2022
Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies.
Journal: Frontiers in medicine
Published: August 20, 2021
Selective ablation of atrial ganglionated plexus attenuates vasovagal reflex in a canine model.
Journal: Pacing and clinical electrophysiology : PACE
Published: July 12, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026